Aristides Capital’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,206
Closed -$215K 166
2022
Q2
$215K Hold
2,206
0.15% 112
2022
Q1
$207K Buy
+2,206
New +$207K 0.13% 135